Dynamic Epigenetic Regulation by Menin During Pancreatic Islet Tumor Formation
Open Access
- 1 April 2015
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 13 (4) , 689-698
Abstract
The tumor suppressor gene MEN1 is frequently mutated in sporadic pancreatic neuroendocrine tumors (PanNET) and is responsible for the familial multiple endocrine neoplasia type 1 (MEN-1) cancer syndrome. Menin, the protein product of MEN1, associates with the histone methyltransferases (HMT) MLL1 (KMT2A) and MLL4 (KMT2B) to form menin–HMT complexes in both human and mouse model systems. To elucidate the role of methylation of histone H3 at lysine 4 (H3K4) mediated by menin–HMT complexes during PanNET formation, genome-wide histone H3 lysine 4 trimethylation (H3K4me3) signals were mapped in pancreatic islets using unbiased chromatin immunoprecipitation coupled with next-generation sequencing (ChIP-seq). Integrative analysis of gene expression profiles and histone H3K4me3 levels identified a number of transcripts and target genes dependent on menin. In the absence of Men1, histone H3K27me3 levels are enriched, with a concomitant decrease in H3K4me3 within the promoters of these target genes. In particular, expression of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) gene is subject to dynamic epigenetic regulation by Men1-dependent histone modification in a time-dependent manner. Decreased expression of IGF2BP2 in Men1-deficient hyperplastic pancreatic islets is partially reversed by ablation of RBP2 (KDM5A), a histone H3K4-specific demethylase of the jumonji, AT-rich interactive domain 1 (JARID1) family. Taken together, these data demonstrate that loss of Men1 in pancreatic islet cells alters the epigenetic landscape of its target genes. Implications: Epigenetic profiling and gene expression analysis in Men1-deficient pancreatic islet cells reveals vital insight into the molecular events that occur during the progression of pancreatic islet tumorigenesis. Mol Cancer Res; 13(4); 689–98. ©2014 AACR.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lackingRb1orMen1Proceedings of the National Academy of Sciences, 2011
- ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activityNucleic Acids Research, 2011
- Histone Methylation by PRC2 Is Inhibited by Active Chromatin MarksMolecular Cell, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- ChIP-chip versus ChIP-seq: Lessons for experimental design and data analysisBMC Genomics, 2011
- Global Analysis of H3K4 Methylation Defines MLL Family Member Targets and Points to a Role for MLL1-Mediated H3K4 Methylation in the Regulation of Transcriptional Initiation by RNA Polymerase IIMolecular and Cellular Biology, 2009
- Molecular Regulation of H3K4 Trimethylation by Wdr82, a Component of Human Set1/COMPASSMolecular and Cellular Biology, 2008
- Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencingNucleic Acids Research, 2008
- Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2Genes & Development, 2008
- Histone trimethylation and the maintenance of transcriptional ONand OFF states by trxG and PcG proteinsGenes & Development, 2006